Leslie Li, Ph.D.

Leslie Li, Ph.D. Email and Phone Number

BD and Vice President of Pharmacology and Translational Medicine @ YIRUI Pharmaceutical Technology
Florida, United States
Leslie Li, Ph.D.'s Location
Miami-Fort Lauderdale Area, United States
About Leslie Li, Ph.D.

I am a self-motivated and strategic scientist who applies knowledge and professional skills of translation research to IND development and biomarker discovery. I have accomplished 25+ time-sensitive related projects that enhanced my capacity of managing budgets, facilities, and teamwork efficiently.With a background in immunology and oncology, I have 7+ years' experience in clinical project management. I am familiar with FDA regulations, GCP& ICH guidelines, HIPPA, and R&D regulations (e.g., IRB, IACUC, Biosafety, etc.), knowing GLP, implementing preclinical/clinical studies, and building a cohesive relationship with PIs, collaborators, CRCs, MSLs, GCP auditors, and phase I lab. I also established SOPs for identifying biomarkers of clinical diagnosis.I have published 25+ peer-reviewed articles and given 15+ poster presentations and 4 oral presentations at regional and international meetings. Additionally, I have 10+ years' experience in leadership skills, extensive laboratory analysis, and computer skills that allow me to serve as an ad-hoc reviewer of 10+ peer-reviewed journals, an editor of CPQ Cancer, a voter/reviewer of R&D subcommittees in Miami VA Medical Center, and a Lead/Head of Pharmacology and Translational Medicine teams in pharmaceutical companies.

Leslie Li, Ph.D.'s Current Company Details
YIRUI Pharmaceutical Technology

Yirui Pharmaceutical Technology

View
BD and Vice President of Pharmacology and Translational Medicine
Florida, United States
Employees:
4
Leslie Li, Ph.D. Work Experience Details
  • Yirui Pharmaceutical Technology
    Bd And Vice President Of Pharmacology And Translational Medicine
    Yirui Pharmaceutical Technology
    Florida, United States
  • Yirui Pharmaceutical Technology
    Bd & Vice President Of Pharmacology And Translational Medicine
    Yirui Pharmaceutical Technology Dec 2022 - Present
  • Zenshine Pharmaceuticals
    Consultant
    Zenshine Pharmaceuticals Dec 2022 - May 2023
    United States
  • Zenshine Pharmaceuticals
    Senior Director, Biology & Translational Medicine
    Zenshine Pharmaceuticals Jan 2022 - Dec 2022
  • Zenshine Pharmaceuticals
    Director, Biology
    Zenshine Pharmaceuticals Aug 2020 - Jan 2022
  • Taipei Medical University Hospital
    Research Consultant/Collaborator
    Taipei Medical University Hospital 2010 - Jan 2023
    Taipei City, Taiwan
    ♦ Strategic thinker that guided a new lab to participate in the development Novartis Oncology Pipeline to eliminate medulloblastoma and cancer stem cells resulting in 3 grants funded by Taipei-Medical Center, 2 publications, 1 poster presentation at the SNO Meeting, and 1 oral presentation at the WFNS Meeting.♦ Effectively inspired KOLs for experimental design, data analysis, and created proposals of material transfer agreements and protocols per R&D regulations.
  • Bruce W. Carter Va Medical Center
    Research Consultant
    Bruce W. Carter Va Medical Center Apr 2019 - Sep 2022
    Miami, Usa
  • Bruce W. Carter Va Medical Center
    Research Scientist | Manager Of The Facs Core Facility | Clinical Research Professional
    Bruce W. Carter Va Medical Center Aug 2018 - Mar 2019
    Miami, Usa
    ♦ Executed time-sensitive projects and worked with a cross-functional group of experts to develop strategies targeting unique metabolic pathways in drug-resistant melanoma cells and tumor-infiltrating immunosuppressive cells (e.g., MDSC and M2 macrophage).♦ Manage the FACS Core Facility, mentored researchers at all levels in FACS analysis (BD Accuri C6 and Beckman CytoFLEX), and provided professional consulting and cell sorting services (Beckman MoFlo Astrios EQ) to customers at the Miami VA Medical Center (VAMC).♦ Established SOPs of sample analysis, and discovered circulating biomarkers (serum cytokines and exosomal microRNAs) that can be used to predict response to pembrolizumab in hepatoma patients resulting in 1 poster presentation at the ASCO Annual Meeting and 1 clinical article; presented clinical data and scientific insights to stakeholders of collaborative companies.♦ Built a team with scientific experts (SE) and managed teamwork for writing research articles on cancer immunotherapy.
  • Genscript
    Sr. Account Manager
    Genscript Mar 2020 - Aug 2020
    Greater New York City Area
  • Beckman Coulter Diagnostics
    Development Scientist
    Beckman Coulter Diagnostics Apr 2019 - Mar 2020
    Miami, Usa
    ♦ Worked effectively in a multidisciplinary team environment, implemented gap analysis for urinalysis (UA) devices/consumables per IVDR/IVD registration in support of regulatory submissions, and developed gap closure plans.♦ Created protocols of testing stability of logistics & distribution (LD) and IVDR products by studying industry publications/presentations and summarizing previous test documents.♦ Exercised analytical judgment on a broad range of issues that impact product development to achieve objectives.
  • University Of Miami,  Miller School Of Medicine
    Postdoctoral Researcher | Clinical Research Professional | Public Speaker | Relationship Builder
    University Of Miami, Miller School Of Medicine May 2016 - Jul 2018
    Miami, Usa
    ♦ Discovered RNF44 triggering a metabolic switch in BRAFi/MEKi-resistant melanoma using proteomic analysis resulting in 1 oral presentation at the AACR Meeting, 2 peer-reviewed articles, and 2 grants (~$1M) funded by VAMC and Sylvester Comprehensive Cancer Center (SCCC).♦ Executed clinical trials of pembrolizumab (phase II, NCT02658019, Merck & Co) and pasireotide (phase II, NCT01639352, Novartis) for hepatoma patients, developed SOPs for sample analysis, and communicated with key opinion leaders (KOLs), CRCs, QA, GCP auditors, Phase I lab, and collaborators (e.g., Ocean Ridge Biosciences) resulting in 1 poster presentation at SCCC Research Retreat 2017 and 2 articles published in peer-reviewed journals.♦ Demonstrated leadership and problem-solving skills of project management by mentoring 2 graduate researchers and 1 technician resulting in 3 collaborative articles.
  • University Of Miami,  Miller School Of Medicine
    Graduate Researcher | Preclinical Research Professional | Public Speaker
    University Of Miami, Miller School Of Medicine Aug 2011 - Apr 2016
    Miami, Florida
    ♦Studied the anti-tumor effect of ADI-PEG20 treatment/arginine deprivation combined with cisplatin or TRAIL on melanoma, mesothelioma, and lung cancer resulting in 3 peer-reviewed articles, 1 book chapter, 2 grants funded by NIH and Polaris , Inc., and 7 poster presentations at the AACR Meeting and Miami VA Research Week.♦Mentored new researchers in identifying the role of procollagen type I in glioblastoma using protein kinase arrays, tissues arrays, and gene cloning resulting in 3 poster presentations at the AACR Meeting 2014-2016.♦Excellent communicator as a lab liaison that built a relationship with bioscience companies to expedite data generation, and reduce 30-40% research expenses by negotiating prices.
  • Kinkoo Biotechnology, Ltd
    Technical Manager | Relationship Builder
    Kinkoo Biotechnology, Ltd 2010 - 2011
    Taiwan
    ♦ Developed 8+ one- or two-step commercial kits for research (e.g., MTT assay kits, DNA loading dye, staining kits, etc.) and provided a top-notch customer service. ♦ Relationship builder that obtained dealerships from biotech companies in China, the United States, and Israel.
  • Chang Gung Memorial Hospital
    Research Associate | Preclinical/Clinical Research Professional
    Chang Gung Memorial Hospital 2004 - 2010
    Linkou, New Taipei City, Taiwan
    ♦ Verified the role of IL-6 paracrine/polymorphisms (SNPs) in colorectal cancer cells and macrophages by analyzing tumor/blood samples from 129 patients brining on 6 publications. ♦ Executed multiple projects including a clinical trial of dendritic cell therapy for melanoma; established a SOP of detecting EGFR mutations/deletions for gefitinib treatment in lung cancer patients and hence made a profit from this diagnostic service for Oncology Department.♦ Implemented a project on CD8+ T cell-Treg cell interaction using transgenic mouse models, ex-vivo explant cultures, and FACS analysis (BD FACSCalibur and BD FACSAria) resulting in 2 grants (~$0.5M) funded by NHRH and Chang Gung Memorial Hospital.
  • Chang Gung University
    Teaching Assistant
    Chang Gung University Sep 2001 - Jun 2003
    Taiwan
    ♦Assisted undergraduate 300+ students in doing experiments and graded their papers in Biochemistry class.

Leslie Li, Ph.D. Education Details

Frequently Asked Questions about Leslie Li, Ph.D.

What company does Leslie Li, Ph.D. work for?

Leslie Li, Ph.D. works for Yirui Pharmaceutical Technology

What is Leslie Li, Ph.D.'s role at the current company?

Leslie Li, Ph.D.'s current role is BD and Vice President of Pharmacology and Translational Medicine.

What schools did Leslie Li, Ph.D. attend?

Leslie Li, Ph.D. attended University Of Miami, Miller School Of Medicine, Chang Gung University, National Chung Hsing University.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.